BCM
SRRA

Brookstone Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Brookstone Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-411
Closed -$28K – 497
2019
Q1 		$28K Buy
+411
New +$26.4K ﹤0.01% 393

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brookstone Capital Management's SRRA Position: Q2 2019 in Review

Brookstone Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2019, closing a stake of 411 shares — an estimated $28K sold.

Brookstone Capital Management first reported a position in SRRA in Q1 2019 and held it in 1 quarter. The position peaked at $28K in Q1 2019. 49 funds tracked by Wall St. Rank hold SRRA as of Q2 2019.

  • Brookstone Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Brookstone Capital Management sold 411 Sierra Oncology, Inc. Common Stock shares in Q2 2019, an estimated $28K.
  • Brookstone Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Brookstone Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $28K in Q1 2019.
  • 49 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2019.

Based on Brookstone Capital Management's 13F filing for Q2 2019, filed 25 Jul 2019.